Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2
Mesenchymal stem cells (MSCs), defined as plastic adherent cells with multipotent differentiation capacity in vitro, are an emerging and valuable tool to treat a plethora of diseases due to their therapeutic mechanisms such as their paracrine activity, mitochondrial and organelle transfer, and trans...
Saved in:
Main Authors: | Karen J. Juárez-Navarro, Eduardo Padilla-Camberos, Néstor Fabián Díaz, Ariel Miranda-Altamirano, N. Emmanuel Díaz-Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/8892189 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01) -
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
by: Mohammad Alghounaim, et al.
Published: (2022-06-01) -
Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01) -
Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2
by: Seife Yohannes, et al.
Published: (2022-01-01) -
A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period
by: Xiaona Li, et al.
Published: (2023-01-01)